Over the past 12 months, 2 insiders at Perspective Therapeutics, Inc. filed 2 open-market SEC Form 4 transactions on CATX: 2 purchases worth $42K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Nov 13, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 25 | Jonathan Robert HuntChief Accounting Officer | BUY | 11.0K | $2.03 | $22K |
| Nov 12, 25 | Robert F Williamson IIIDirector | BUY | 9.5K | $2.10 | $20K |
| Mar 31, 25 | Lori A WoodsDirector | BUY | 23.5K | $2.13 | $50K |
| Mar 31, 25 | Robert F Williamson IIIDirector | BUY | 38.1K | $2.14 | $82K |
| Mar 28, 25 | Juan GrahamChief Financial Officer | BUY | 33.3K | $2.25 | $75K |
| Mar 28, 25 | Johan M. SpoorChief Executive Officer | BUY | 22.0K | $2.24 | $49K |
| Mar 28, 25 | Robert F Williamson IIIDirector | BUY | 22.2K | $2.27 | $50K |
| Dec 4, 24 | Heidi HensonDirector | BUY | 26.0K | $3.85 | $100K |
| Dec 4, 24 | Johan M. SpoorCEO | BUY | 8.0K | $3.77 | $30K |
| Nov 25, 24 | Jonathan Robert HuntChief Financial Officer | BUY | 10.0K | $3.94 | $39K |
| Nov 25, 24 | Johan M. SpoorCEO | BUY | 14.5K | $3.80 | $55K |
| Nov 25, 24 | Robert F Williamson IIIDirector | BUY | 3.6K | $3.67 | $13K |
| Jun 17, 24 | Jonathan Robert HuntChief Financial Officer | BUY | 1.8K | $9.82 | $18K |
| Jun 14, 24 | Lori A WoodsDirector | BUY | 4.5K | $10.90 | $49K |
| Jun 13, 24 | Johan M. SpoorCEO | BUY | 100.0K | $1.17 | $117K |
| Jun 3, 24 | Lori A WoodsDirector | BUY | 34.2K | $1.46 | $50K |
| May 31, 24 | Jonathan Robert HuntChief Financial Officer | BUY | 13.0K | $1.40 | $18K |
| May 31, 24 | Robert F Williamson IIIDirector | BUY | 55.0K | $1.38 | $76K |
| May 29, 24 | Robert F Williamson IIIDirector | BUY | 18.7K | $1.34 | $25K |
| Jan 30, 24 | Robert F Williamson IIIDirector | BUY | 57.1K | $0.72 | $41K |
| Jan 29, 24 | Robert F Williamson IIIDirector | BUY | 21.2K | $0.64 | $14K |
| Jan 26, 24 | Robert F Williamson IIIDirector | BUY | 50.0K | $0.61 | $27K |
| Jan 25, 24 | Robert F Williamson IIIDirector | BUY | 22.1K | $0.49 | $11K |
| Jan 24, 24 | Markus PuhlmannChief Medical Officer | BUY | 280.0K | $0.50 | $140K |
| Jan 24, 24 | Robert F Williamson IIIDirector | BUY | 29.9K | $0.49 | $15K |
| Dec 21, 23 | Robert F Williamson IIIDirector | BUY | 3.7K | $0.33 | $1K |
| Dec 19, 23 | Robert F Williamson IIIDirector | BUY | 13.7K | $0.32 | $4K |
| Dec 19, 23 | Markus PuhlmannChief Medical Officer | BUY | 400.0K | $0.34 | $136K |
| Dec 18, 23 | Jonathan Robert HuntChief Financial Officer | BUY | 125.0K | $0.26 | $33K |
| Dec 18, 23 | Robert F Williamson IIIDirector | BUY | 10.0K | $0.26 | $3K |
| Dec 18, 23 | Markus PuhlmannChief Medical Officer | BUY | 60.4K | $0.26 | $16K |
| Dec 15, 23 | Markus PuhlmannChief Medical Officer | BUY | 135.0K | $0.27 | $36K |
| Dec 15, 23 | Lori A WoodsDirector | BUY | 153.0K | $0.27 | $41K |
| Dec 14, 23 | Lori A WoodsDirector | BUY | 32.2K | $0.27 | $9K |
Over the past 12 months, insiders at Perspective Therapeutics, Inc. filed 2 open-market purchases worth $42K and 0 sales worth $0 on CATX, which makes them net buyers over the period. The most recent Form 4 was filed on Nov 13, 25.
The largest recent open-market CATX insider purchase in our data was $140K by Markus Puhlmann, Chief Medical Officer, filed on Jan 24, 24.
2 different insiders at Perspective Therapeutics, Inc. filed open-market SEC Form 4 transactions on CATX over the last 12 months.
InsiderTape plots every CATX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Perspective Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →